RECRUITINGOBSERVATIONAL
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
A Multi-center, Open, Long-term Follow-up Study to Evaluate the Efficacy and Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis : 5-year Results From the K0202 Extension Study
About This Trial
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
Who May Be Eligible (Plain English)
Who May Qualify:
1. Subject who enrolled K0202 Clinical Trial(parent study) and has been given more than one medication.
2. Subjects who understand and voluntarily sign an willing to sign a consent form form
Who Should NOT Join This Trial:
1\. Any other condition which the investigator judges would make patient unsuitable for study participation
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Subject who enrolled K0202 Clinical Trial(parent study) and has been given more than one medication.
2. Subjects who understand and voluntarily sign an informed consent form
Exclusion Criteria:
1\. Any other condition which the investigator judges would make patient unsuitable for study participation
Treatments Being Tested
OTHER
Not applicable(observational study)
Not applicable(observational study)
Locations (1)
Seoul national University Boramae medical center
Seoul, South Korea